Legalizing Premium Health Care Act of 2026
SB 4583, titled the Legalizing Premium Health Care Act of 2026, would amend the Medicare statute to create a formal payment and contracting option for Medicare beneficiaries and eligible professionals. The bill would allow beneficiaries to enter into written contracts with participating or non-participating physicians or practitioners for Medicare-covered items and services, while still preserving the beneficiary’s ability to submit Medicare claims for those services. It also provides that payment would generally be made under Medicare rules, but without treating the professional’s services under the contract as changing that professional’s participation status for other patients or services.
The bill includes consumer-protection conditions for these contracts. They must be in writing, signed before services are provided, spell out payment terms, and cannot be entered into during an emergency medical condition or urgent health care situation. The contract must also disclose key rights and responsibilities, including that the beneficiary may remain responsible for filing claims unless the contract says otherwise, and that certain Medicare payment limits and incentives would not apply to the contracted services. Dual-eligible beneficiaries—those also eligible for Medicaid—would be excluded from using this contracting option.
The bill would amend Section 1802 of the Social Security Act and make a conforming change to Section 1814, altering how Medicare fee-for-service beneficiaries may privately contract with providers. It would also preempt state laws that limit the amount eligible professionals may charge for services paid under Medicare, extending that preemption to states and U.S. territories. In practical terms, the measure would expand provider and beneficiary flexibility in Medicare billing and contracting, while preserving Medicare payment access for covered services under the new arrangement.
There is limited recorded legislative sentiment because the bill was only introduced, read twice, and referred to the Senate Committee on Finance, with no committee transcript or vote history provided. Based on the text and title, the bill appears to be framed as a pro-choice, pro-contracting measure intended to expand patient and physician freedom in Medicare. The absence of recorded debate or votes means there is no documented bipartisan or partisan reaction in the available materials.
The main points of contention likely center on whether the bill weakens Medicare’s traditional protections and pricing controls by allowing private contracting and preempting state charge limits. Critics could object that the measure may increase out-of-pocket costs, reduce oversight, or create confusion about beneficiary rights, especially because it permits contracts outside some standard Medicare constraints. Supporters would likely emphasize patient autonomy, provider flexibility, and the ability to negotiate premium or customized care arrangements. The exclusion of dual-eligible beneficiaries and the ban on contracting during emergencies suggest an effort to limit abuse and protect vulnerable patients, but those provisions may also be viewed as narrowing the bill’s reach.